4.7 Review

Involvement of Inflammasome Components in Kidney Disease

期刊

ANTIOXIDANTS
卷 11, 期 2, 页码 -

出版社

MDPI
DOI: 10.3390/antiox11020246

关键词

acute kidney injury; chronic kidney disease; kidney transplantation; inflammasome; redox signalling; endoplasmic reticulum stress; interleukin-18; interleukin-1 beta; NLRP3; AIM2; caspase-8

资金

  1. Consejo Nacional de Ciencia y Tecnologia (CONACyT) [A1-S-7495]
  2. Direccion General de Asuntos del Personal Academico (DGAPA) [IN200922]
  3. [CVU 818062]

向作者/读者索取更多资源

Inflammasomes play an important role in the innate immune response. Animal models of kidney diseases have shown their involvement in inflammation, pyroptosis, and fibrosis. Besides the commonly studied NLRP3, other inflammasome components are also important in kidney disease. The interaction of inflammasome components with redox signaling, endoplasmic reticulum stress, and mitochondrial function is a research focus.
Inflammasomes are multiprotein complexes with an important role in the innate immune response. Canonical activation of inflammasomes results in caspase-1 activation and maturation of cytokines interleukin-1 beta and -18. These cytokines can elicit their effects through receptor activation, both locally within a certain tissue and systemically. Animal models of kidney diseases have shown inflammasome involvement in inflammation, pyroptosis and fibrosis. In particular, the inflammasome component nucleotide-binding domain-like receptor family pyrin domain containing 3 (NLRP3) and related canonical mechanisms have been investigated. However, it has become increasingly clear that other inflammasome components are also of importance in kidney disease. Moreover, it is becoming obvious that the range of molecular interaction partners of inflammasome components in kidney diseases is wide. This review provides insights into these current areas of research, with special emphasis on the interaction of inflammasome components and redox signalling, endoplasmic reticulum stress, and mitochondrial function. We present our findings separately for acute kidney injury and chronic kidney disease. As we strictly divided the results into preclinical and clinical data, this review enables comparison of results from those complementary research specialities. However, it also reveals that knowledge gaps exist, especially in clinical acute kidney injury inflammasome research. Furthermore, patient comorbidities and treatments seem important drivers of inflammasome component alterations in human kidney disease.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据